Cargando…
Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001227/ https://www.ncbi.nlm.nih.gov/pubmed/33804066 http://dx.doi.org/10.3390/diagnostics11030519 |
_version_ | 1783671180688883712 |
---|---|
author | Markousis-Mavrogenis, George Poulos, George Dimitroulas, Theodoros Giannakopoulou, Aikaterini Mavragani, Clio Vartela, Vasiliki Manolopoulou, Dionysia Kolovou, Genovefa Voulgari, Paraskevi Sfikakis, Petros P. Kitas, George D. Mavrogeni, Sophie I. |
author_facet | Markousis-Mavrogenis, George Poulos, George Dimitroulas, Theodoros Giannakopoulou, Aikaterini Mavragani, Clio Vartela, Vasiliki Manolopoulou, Dionysia Kolovou, Genovefa Voulgari, Paraskevi Sfikakis, Petros P. Kitas, George D. Mavrogeni, Sophie I. |
author_sort | Markousis-Mavrogenis, George |
collection | PubMed |
description | Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of ischaemic/non-ischaemic arrhythmogenic substrates in those with and without autoimmune rheumatic diseases (ARDs). In total, 80 consecutive patients (40 with ARDs, 40 with non-ARD-related cardiac pathology) with NSVT in the past 15 days and preserved left ventricular ejection fraction were examined using a 1.5-T system. Evaluated parameters included biventricular volumes/ejection fractions, T2 signal ratio, early/late gadolinium enhancement (EGE/LGE), T1 and T2 mapping and extracellular volume fraction (ECV). Mean age did not differ across groups, but patients with ARDs were more often women (32 (80%) vs. 15 (38%), p < 0.001). Biventricular systolic function, T2 signal ratio and EGE and LGE extent did not differ significantly between groups. Patients with ARDs had significantly higher median native T1 mapping (1078.5 (1049.0–1149.0) vs. 1041.5 (1014.0–1079.5), p = 0.003), higher ECV (31.0 (29.0–32.0) vs. 28.0 (26.5–30.0), p = 0.003) and higher T2 mapping (57.5 (54.0–61.0) vs. 52.0 (48.0–55.5), p = 0.001). In patients with ARDs, the distribution of cardiac fibrosis followed a predominantly non-ischaemic pattern, with ischaemic patterns being more common in those without ARDs (p < 0.001). After accounting for age and cardiovascular comorbidities, most findings remained unaffected, while only tissue characterisation indices remained significant after additionally correcting for sex. Patients with ARDs had a predominantly non-ischaemic myocardial scar pattern and showed evidence of diffuse inflammatory/ischaemic changes (elevated native T1-/T2-mapping and ECV values) independent of confounding factors. |
format | Online Article Text |
id | pubmed-8001227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80012272021-03-28 Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction Markousis-Mavrogenis, George Poulos, George Dimitroulas, Theodoros Giannakopoulou, Aikaterini Mavragani, Clio Vartela, Vasiliki Manolopoulou, Dionysia Kolovou, Genovefa Voulgari, Paraskevi Sfikakis, Petros P. Kitas, George D. Mavrogeni, Sophie I. Diagnostics (Basel) Article Non-sustained ventricular tachycardia (NSVT) is a potentially lethal arrhythmia that is most commonly attributed to coronary artery disease. We hypothesised that among patients with NSVT and preserved ejection fraction, cardiovascular magnetic resonance (CMR) would identify a different proportion of ischaemic/non-ischaemic arrhythmogenic substrates in those with and without autoimmune rheumatic diseases (ARDs). In total, 80 consecutive patients (40 with ARDs, 40 with non-ARD-related cardiac pathology) with NSVT in the past 15 days and preserved left ventricular ejection fraction were examined using a 1.5-T system. Evaluated parameters included biventricular volumes/ejection fractions, T2 signal ratio, early/late gadolinium enhancement (EGE/LGE), T1 and T2 mapping and extracellular volume fraction (ECV). Mean age did not differ across groups, but patients with ARDs were more often women (32 (80%) vs. 15 (38%), p < 0.001). Biventricular systolic function, T2 signal ratio and EGE and LGE extent did not differ significantly between groups. Patients with ARDs had significantly higher median native T1 mapping (1078.5 (1049.0–1149.0) vs. 1041.5 (1014.0–1079.5), p = 0.003), higher ECV (31.0 (29.0–32.0) vs. 28.0 (26.5–30.0), p = 0.003) and higher T2 mapping (57.5 (54.0–61.0) vs. 52.0 (48.0–55.5), p = 0.001). In patients with ARDs, the distribution of cardiac fibrosis followed a predominantly non-ischaemic pattern, with ischaemic patterns being more common in those without ARDs (p < 0.001). After accounting for age and cardiovascular comorbidities, most findings remained unaffected, while only tissue characterisation indices remained significant after additionally correcting for sex. Patients with ARDs had a predominantly non-ischaemic myocardial scar pattern and showed evidence of diffuse inflammatory/ischaemic changes (elevated native T1-/T2-mapping and ECV values) independent of confounding factors. MDPI 2021-03-15 /pmc/articles/PMC8001227/ /pubmed/33804066 http://dx.doi.org/10.3390/diagnostics11030519 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Markousis-Mavrogenis, George Poulos, George Dimitroulas, Theodoros Giannakopoulou, Aikaterini Mavragani, Clio Vartela, Vasiliki Manolopoulou, Dionysia Kolovou, Genovefa Voulgari, Paraskevi Sfikakis, Petros P. Kitas, George D. Mavrogeni, Sophie I. Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title | Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title_full | Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title_fullStr | Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title_full_unstemmed | Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title_short | Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction |
title_sort | ventricular tachycardia has mainly non-ischaemic substrates in patients with autoimmune rheumatic diseases and a preserved ejection fraction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001227/ https://www.ncbi.nlm.nih.gov/pubmed/33804066 http://dx.doi.org/10.3390/diagnostics11030519 |
work_keys_str_mv | AT markousismavrogenisgeorge ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT poulosgeorge ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT dimitroulastheodoros ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT giannakopoulouaikaterini ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT mavraganiclio ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT vartelavasiliki ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT manolopouloudionysia ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT kolovougenovefa ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT voulgariparaskevi ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT sfikakispetrosp ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT kitasgeorged ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction AT mavrogenisophiei ventriculartachycardiahasmainlynonischaemicsubstratesinpatientswithautoimmunerheumaticdiseasesandapreservedejectionfraction |